IDEXX Laboratories, Inc. ( IDXX) - Key Metrics
IDXX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $15.19 | $4.23 | $4.33 | $4.03 |
| 2026Q1 | $14.24 | $3.48 | $3.32 | $2.92 |
| 2025Q4 | $13.62 | $3.10 | $4.40 | $4.03 |
| 2025Q3 | $13.80 | $3.43 | $5.02 | $4.63 |
| 2025Q2 | $13.80 | $3.66 | $2.31 | $1.89 |
IDXX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 31.11 |
| 2026Q1 | 0% | 40.37 |
| 2025Q4 | 0% | 54.56 |
| 2025Q3 | 0% | 46.57 |
| 2025Q2 | 0% | 36.64 |
IDXX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.76% | 0% |
| 2026Q1 | 0.52% | 0% |
| 2025Q4 | 0.60% | 0% |
| 2025Q3 | 0.73% | 0% |
| 2025Q2 | 0.35% | 0% |
IDXX
Price: $518
52 week price:
Earnings Per Share: 14.26 USD
P/E Ratio: 41.14
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 353885
Ebitda: 120.9 millionMarket Capitalization: 41.6 billion